Xtant Medical Holdings, Inc. (XTNT) stock
XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3080% below fair value
$0.21−0.00 (-2.19%)
Close on Nov 17, 2026Market cap $28.79MP/E –Yield –
Xtant Medical pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Xtant Medical's pe ratio was 43.0× on Jul 31, 2026, against 92.0× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 43.0× | −35.4 |
| 2025 | Dec 31, 2025 | 78.4× | −10.6 |
| 2024 | Apr 30, 2024 | 89.0× | −24.0 |
| 2023 | Dec 29, 2023 | 113.0× | – |
See a number that looks wrong?